NEW YORK (GenomeWeb) – KeyGene today announced it has licensed its sequencing-based genotyping technology to the University of Edinburgh for research purposes.
The license includes access to and use of KeyGene's restricted-site associated DNA sequencing technology. The SBG technology enables the discovery and scoring of genetic variation for improving crops without prior knowledge of the genome sequence and provides researchers with a method to conduct genome-wide SNP discovery and genotyping in a single experiment, KeyGene said.
Financial and other terms of the deal were not disclosed.
"With this license and the support of KeyGene, we will be able to drive further discoveries in crop, animal, and environmental science," Edinburgh Genomics Director Mark Blaxter said in a statement. The genomics and bioinformatics facility is based at the University of Edinburgh.